Nicholas Veomett

436 total citations
6 papers, 328 citations indexed

About

Nicholas Veomett is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nicholas Veomett has authored 6 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nicholas Veomett's work include CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Renal and related cancers (3 papers). Nicholas Veomett is often cited by papers focused on CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Renal and related cancers (3 papers). Nicholas Veomett collaborates with scholars based in United States. Nicholas Veomett's co-authors include David A. Scheinberg, Dmitry Pankov, Michael Curcio, Tao Dao, Liu C, Richard J. O’Reilly, Tatyana Korontsvit, Ekaterina Doubrovina, Andrew Scott and Jingyi Xiang and has published in prestigious journals such as Blood, Nature Biotechnology and Clinical Cancer Research.

In The Last Decade

Nicholas Veomett

6 papers receiving 319 citations

Peers

Nicholas Veomett

ONCOL

IMMUN

MB

RNMI

GENET

Natalie Duerkopp United States

Martin G. Klatt United States

Vladimir Senyukov United States

Roeland Lameris Netherlands

Torben Altmann Germany

Marika Sherman United States

Horst Hummel Germany

Laura Cons Switzerland

Chris Martin United States

Beatrix Kotlán Hungary

Natalie Duerkopp United States

Nicholas Veomett

228 ×0.9

ONCOL

246 ×1.4

IMMUN

97 ×0.8

MB

50 ×0.4

RNMI

85 ×1.9

GENET

Citations per year, relative to Nicholas Veomett Nicholas Veomett (= 1×) peers Natalie Duerkopp

Countries citing papers authored by Nicholas Veomett

Since Specialization

Citations

This map shows the geographic impact of Nicholas Veomett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Veomett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Veomett more than expected).

Fields of papers citing papers by Nicholas Veomett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Veomett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Veomett. The network helps show where Nicholas Veomett may publish in the future.

Co-authorship network of co-authors of Nicholas Veomett

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Veomett. A scholar is included among the top collaborators of Nicholas Veomett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Veomett. Nicholas Veomett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Dao, Tao, Dmitry Pankov, Andrew Scott, et al.. (2015). Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. Nature Biotechnology. 33(10). 1079–1086. 126 indexed citations

2.

Veomett, Nicholas, Tao Dao, Hong Liu, et al.. (2014). Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein. Clinical Cancer Research. 20(15). 4036–4046. 41 indexed citations

3.

Dao, Tao, Su Yan, Nicholas Veomett, et al.. (2013). Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody. Science Translational Medicine. 5(176). 176ra33–176ra33. 136 indexed citations

4.

Pankov, Dmitry, Tao Dao, Andrew Scott, et al.. (2013). A Bi-Specific T Cell Engaging Monoclonal Antibody (mAb) Derived From a TCR-Like Mab Specific For WT1/HLA-A0201 (ESK-BiTE) Shows a Potent Activity Against Human AML and Ph+ ALL In Mouse Models. Blood. 122(21). 2521–2521. 2 indexed citations

5.

Mallikaratchy, Prabodhika, Lars Ulrik Nordstrøm, Nicholas Veomett, et al.. (2013). A Self-Assembling Short Oligonucleotide Duplex Suitable for Pretargeting. Nucleic Acid Therapeutics. 23(4). 289–299. 10 indexed citations

6.

Shum, David, Bhavneet Bhinder, Nicholas Veomett, et al.. (2011). A High-Throughput Scintillation Proximity-Based Assay for Human DNA Ligase IV. Assay and Drug Development Technologies. 10(3). 235–249. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact